Growth hormone (hGH) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Growth hormone (hGH) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Hormones diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-187-1 | 1. BSA-Growth hormone (hGH) 2. Anti-Growth hormone (hGH) mouse monoclonal antibody | $2709.00 |
GMP-SMT-187-2 | 1. OVA-Growth hormone (hGH) 2. Anti-Growth hormone (hGH) mouse monoclonal antibody | $2709.00 |
GMP-SMT-187-3 | 1. BSA-Growth hormone (hGH) 2. Anti-Growth hormone (hGH) human monoclonal antibody | $2709.00 |
GMP-SMT-187-4 | 1. OVA-Growth hormone (hGH) 2. Anti-Growth hormone (hGH) human monoclonal antibody | $2709.00 |
GMP-SMT-187-Ag-1 | BSA-Growth hormone (hGH) | $756.00 |
GMP-SMT-187-Ag-2 | OVA-Growth hormone (hGH) | $756.00 |
GMP-SMT-187-Ab-1 | Anti-Growth hormone (hGH) mouse monoclonal antibody | $1953.00 |
GMP-SMT-187-Ab-2 | Anti-Growth hormone (hGH) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Growth hormone (hGH)
Cat No. | GMP-SMT-187-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Growth hormone (hGH) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Growth hormone (hGH) had been validated with our anti-Hapten antibody Anti-Growth hormone (hGH) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Growth hormone (hGH)
Cat No. | GMP-SMT-187-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Growth hormone (hGH) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Growth hormone (hGH) had been validated with our anti-Hapten antibody Anti-Growth hormone (hGH) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Growth hormone (hGH) mouse monoclonal antibody
Cat No. | GMP-SMT-187-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.1-0.2 |
Products description | The anti-Hapten antibody against hapten Growth hormone (hGH) had been validated with our hapten hapten-carrier conjugates BSA-Growth hormone (hGH) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Growth hormone (hGH) human monoclonal antibody
Cat No. | GMP-SMT-187-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.1-0.2 |
Products description | The anti-Hapten antibody against hapten Growth hormone (hGH) had been validated with our hapten hapten-carrier conjugates BSA-Growth hormone (hGH) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Biomarker Information
Growth Hormone (hGH) in In Vitro Diagnosis: A Comprehensive Exploration
Growth hormone (hGH), known scientifically as human growth hormone or somatotropin, stands as a vital peptide hormone primarily synthesized by the anterior pituitary gland. Within the realm of in vitro diagnosis, particularly in the specialized fields of endocrinology and clinical pathology, the role and significance of hGH are multifaceted and indispensable.
1. Growth Hormone (hGH) in In Vitro Diagnosis (Serial Number 1):
The profound relevance of Growth hormone (hGH) in the domain of in vitro diagnosis is underpinned by its multifunctional roles:
- Growth Disorders Assessment: At its core, hGH is the linchpin in regulating growth and development. Its pivotal role is reflected in its indispensability as a biomarker in the diagnosis of growth disorders. In vitro diagnostic assays designed to measure hGH levels play an instrumental role in enabling clinicians to identify and elucidate conditions such as growth hormone deficiency and hypersecretion.
- Acromegaly Evaluation: In the context of acromegaly, a rare disorder characterized by the hypersecretion of hGH, precise and definitive diagnostic assessments are imperative. In vitro diagnostic assays targeting hGH levels are not merely diagnostic but serve as invaluable tools for the ongoing monitoring of disease progression. This monitoring is essential for refining therapeutic strategies and ensuring optimal patient care.
- Pituitary Tumor Detection: The anterior pituitary gland is a central player in the regulation of hGH secretion. Pathological conditions such as pituitary adenomas can disrupt this finely tuned process. In vitro diagnostic tests focused on hGH assume a pivotal role in the detection of these tumors and, importantly, in assessing their impact on overall hormone production.
- Treatment Efficacy Monitoring: Patients embarked on the journey of growth hormone replacement therapy rely extensively on the regular monitoring of hGH levels via in vitro diagnostic assays. This is a critical aspect of treatment optimization, ensuring that therapeutic regimens are tailored to individual needs, thereby facilitating the attainment of desired therapeutic outcomes.
- Research and Clinical Investigations: Beyond clinical applications, hGH measurements bear significant importance in the realm of research studies and clinical trials. These studies explore the intricate facets of endocrinology, metabolism, and hormonal regulation. In vitro diagnostic precision in hGH measurements underpins the investigation of hGH's effects on diverse physiological processes, ultimately contributing to the advancement of scientific knowledge and the development of innovative therapeutic modalities.
2. The Significance of Measuring Growth Hormone (hGH) (Serial Number 2):
The measurement of Growth hormone (hGH) through in vitro diagnostic assays assumes critical importance for several compelling reasons:
- Clinical Diagnosis: At the forefront, the accurate measurement of hGH levels is foundational for the diagnosis of growth-related disorders. This extends across age groups, encompassing pediatric and adult populations. Precise diagnostic measurements of hGH serve as the keystone for identifying and elucidating the underlying causes of growth abnormalities, thereby guiding clinicians toward appropriate and targeted clinical interventions.
- Treatment Optimization: Within the clinical arena, patients undergoing growth hormone replacement therapy place their trust in the regular monitoring of hGH levels through in vitro diagnostic assays. This monitoring process is quintessential for ensuring that therapy is not only administered but tailored with precision to individual needs. In turn, this dynamic approach serves to optimize therapeutic outcomes, aligning treatment regimens with the specific requirements of each patient.
- Disease Management: Beyond the realms of endocrinology, certain medical conditions, such as acromegaly and pituitary tumors, may exert profound and far-reaching health implications. In vitro diagnostic tests meticulously designed to measure hGH levels serve as pivotal tools for not only the detection of these conditions but, more importantly, for their ongoing monitoring and effective management. In the case of acromegaly, where the pathological hypersecretion of hGH is observed, precise diagnostic measurements are crucial for confirming diagnoses and facilitating continued vigilance in monitoring disease progression.
- Research Advancement: The importance of in vitro diagnostic measurements of hGH extends far beyond clinical applications. The realm of scientific research is enriched by the precise and targeted measurements of hGH levels. This dimension contributes significantly to the expansion of our knowledge in areas such as growth regulation, hormonal signaling, and the myriad of physiological processes influenced by hGH. Consequently, these measurements serve as the linchpin for ongoing research endeavors, fueling innovative discoveries and therapeutic modalities.
- Clinical Trial Facilitation: In the complex landscape of clinical trials and research studies that focus on endocrine disorders, the measurement of hGH via in vitro diagnostics emerges as an indispensable component. These measurements are pivotal in assessing treatment efficacy, safety, and therapeutic responses. This, in turn, bears direct and tangible benefits for patients, facilitating access to cutting-edge treatments and advancing our scientific understanding of growth regulation and hormonal signaling.
In summary, Growth hormone (hGH) emerges as a central and irreplaceable component in the realm of in vitro diagnosis, particularly within the specialized domains of endocrinology and clinical pathology. The meticulous measurement of hGH levels through in vitro assays forms the bedrock for diagnosing a spectrum of growth-related disorders, optimizing treatments, managing diseases, advancing scientific research, and conducting clinical trials. The overarching significance of these measurements reverberates across the spectrum of patient care, therapeutic precision, and the progressive enrichment of our scientific understanding in the intricate realm of hormonal regulation and growth.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.